Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Cohen

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Journal of Neuro-Oncology|February 21, 2019
Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastomaAmaury De Barros, Justine Attal, Margaux Roques, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2012
A new biomarker that predicts colonic neoplasia outcome in patients with hyperplastic colonic polypsCatherine Do, Claudine Bertrand, Julien Palasse, et al.
Cancers|March 27, 2019
Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and StemnessAline Kowalski-Chauvel, Valerie Gouaze-Andersson, Laurent Baricault, et al.
Oncotarget|September 1, 2018
FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarkerValérie Gouazé-Andersson, Marie-Julie Ghérardi, Anthony Lemarié, et al.
Cancer Research|February 21, 2016
FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α PathwayValérie Gouazé-Andersson, Caroline Delmas, Marion Taurand, et al.
Clinical Neurology and Neurosurgery|June 9, 2020
Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational studyAmaury De Barros, Justine Attal, Margaux Roques, et al.
The Prostate|September 25, 2004
Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survivalYuquan Shi, Junmin Wu, Rosemarie Mick, et al.
Neuroradiology|August 27, 2017
Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastomaFatima Tensaouti, Jonathan Khalifa, Amélie Lusque, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal studyAnne Laprie, Isabelle Catalaa, Emmanuelle Cassol, et al.
The Oncologist|June 21, 2025
Clinical outcome and deep learning imaging characteristics of patients treated by radio-chemotherapy for a "molecular" glioblastomaCaroline Zerbib, Lucas Robinet, Soleakhena Ken, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Journal of Neuro-Oncology|February 21, 2019
Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastomaAmaury De Barros, Justine Attal, Margaux Roques, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2012
A new biomarker that predicts colonic neoplasia outcome in patients with hyperplastic colonic polypsCatherine Do, Claudine Bertrand, Julien Palasse, et al.
Cancers|March 27, 2019
Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and StemnessAline Kowalski-Chauvel, Valerie Gouaze-Andersson, Laurent Baricault, et al.
Oncotarget|September 1, 2018
FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarkerValérie Gouazé-Andersson, Marie-Julie Ghérardi, Anthony Lemarié, et al.
Cancer Research|February 21, 2016
FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α PathwayValérie Gouazé-Andersson, Caroline Delmas, Marion Taurand, et al.
Clinical Neurology and Neurosurgery|June 9, 2020
Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational studyAmaury De Barros, Justine Attal, Margaux Roques, et al.
The Prostate|September 25, 2004
Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survivalYuquan Shi, Junmin Wu, Rosemarie Mick, et al.
Neuroradiology|August 27, 2017
Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastomaFatima Tensaouti, Jonathan Khalifa, Amélie Lusque, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal studyAnne Laprie, Isabelle Catalaa, Emmanuelle Cassol, et al.
The Oncologist|June 21, 2025
Clinical outcome and deep learning imaging characteristics of patients treated by radio-chemotherapy for a "molecular" glioblastomaCaroline Zerbib, Lucas Robinet, Soleakhena Ken, et al.
Pageof 11